As of Jun 23
| -0.28 / -0.57%|
The 26 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 49.38, with a high estimate of 59.70 and a low estimate of 37.14. The median estimate represents a +0.69% increase from the last price of 49.04.
The current consensus among 29 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since June, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.